ImageneBio, Inc. (IMA)

ImageneBio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	103.16	12.12	15.32
Short-Term Investments	39.42	-	10.15
Cash & Short-Term Investments	142.58	12.12	25.47
Cash Growth	459.76%	-52.43%	-
Other Receivables	0.73	0.08	0.22
Receivables	0.73	0.08	0.22
Prepaid Expenses	2.34	0.21	0.2
Other Current Assets	1.88	0.06	-
Total Current Assets	147.53	12.47	25.9
Property, Plant & Equipment	0.89	0.56	4.28
Other Long-Term Assets	4.95	2.9	1.07
Total Assets	160.88	15.92	31.25
Accounts Payable	2.08	5.29	5.88
Accrued Expenses	6.9	3.46	3.13
Short-Term Debt	-	7.5	-
Current Portion of Leases	2.16	0.31	0.42
Current Unearned Revenue	-	0.65	0.07
Total Current Liabilities	11.14	17.21	9.49
Long-Term Leases	1.28	0.24	0.57
Long-Term Unearned Revenue	-	-	0.07
Total Liabilities	21.05	17.45	10.13
Common Stock	0.01	0.02	0.01
Additional Paid-In Capital	362.87	2.14	-
Retained Earnings	-223.14	-179.9	-143.33
Comprehensive Income & Other	0.09	-1.79	-1.75
Total Common Equity	139.83	-179.53	-145.08
Shareholders' Equity	139.83	-1.53	21.12
Total Liabilities & Equity	160.88	15.92	31.25
Total Debt	3.45	8.05	0.98
Net Cash (Debt)	139.14	4.07	24.49
Net Cash Growth	468.17%	-83.38%	-
Net Cash Per Share	0.35	0.01	0.08
Filing Date Shares Outstanding	10.65	462.11	320.91
Total Common Shares Outstanding	10.65	462.11	320.91
Working Capital	136.39	-4.74	16.41
Book Value Per Share	13.13	-0.39	-0.45
Tangible Book Value	139.83	-179.53	-145.08
Tangible Book Value Per Share	13.13	-0.39	-0.45
Machinery	-	0.11	3.19
Leasehold Improvements	-	0.23	3.3

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q